Robert Stanley Tutag, Director at CORGENIX MEDICAL CORP/CO (CONX), bought 5,000 shares at $0.11 ($550) on 2010-09-27, disclosed to the SEC on 2010-09-29.
Open-market purchase of $550 CONX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CONX | BUY | 2008-06-03 | $5K | — | Filing → |
| CONX | BUY | 2006-02-28 | $16K | — | Filing → |